EMA Recommendations on Compassionate Use of Remdesivir for COVID-19

April 3, 2020

Applied Clinical Trials

During a virtual meeting held on April 2nd, EMA’s human medicines committee gave recommendations on how the investigational antiviral medicine remdesivir should be used for treating coronavirus disease in compassionate use programs. 

To read the reccomendations, click here.

Related Content:

News